Literature DB >> 20305381

DNA hypomethylation in cancer: epigenetic scars of a neoplastic journey.

Charles De Smet1, Axelle Loriot1.   

Abstract

Cytosine methylation is a heritable modification of DNA in mammalian cells, and has a determinant impact on long-term gene repression and genome stability. Genomic methylation patterns, which remain generally stable in the adult, become profoundly altered in most human tumors. While discrete DNA segments become hypermethylated in cancer cells, many more sequences become hypomethylated. This review discusses our current understanding of the mechanisms that lead to DNA hypomethylation in tumors. Evidence suggests that methylation losses are not random, but rather evolve into mosaic hypomethylation patterns. It is proposed that such hypomethylation patterns result from a historical event of transient DNA demethylation, and that transcriptional regulators contribute to determining which regions escape remethylation and remain therefore unmethylated. Finally, possible stages of tumor development during which the transient DNA demethylation process may take place will be discussed.

Entities:  

Mesh:

Year:  2010        PMID: 20305381     DOI: 10.4161/epi.5.3.11447

Source DB:  PubMed          Journal:  Epigenetics        ISSN: 1559-2294            Impact factor:   4.528


  38 in total

1.  Conservation and divergence of DNA methylation in eukaryotes: new insights from single base-resolution DNA methylomes.

Authors:  Zhixi Su; Leng Han; Zhongming Zhao
Journal:  Epigenetics       Date:  2011-02-01       Impact factor: 4.528

Review 2.  The epigenomic interface between genome and environment in common complex diseases.

Authors:  Christopher G Bell; Stephan Beck
Journal:  Brief Funct Genomics       Date:  2010-11-08       Impact factor: 4.241

3.  Cancer-linked satellite 2 DNA hypomethylation does not regulate Sat2 non-coding RNA expression and is initiated by heat shock pathway activation.

Authors:  Gaëlle Tilman; Nausica Arnoult; Sandrine Lenglez; Amandine Van Beneden; Axelle Loriot; Charles De Smet; Anabelle Decottignies
Journal:  Epigenetics       Date:  2012-06-22       Impact factor: 4.528

Review 4.  Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma.

Authors:  Igor P Pogribny; Ivan Rusyn
Journal:  Cancer Lett       Date:  2012-02-02       Impact factor: 8.679

5.  BORIS/CTCFL expression is insufficient for cancer-germline antigen gene expression and DNA hypomethylation in ovarian cell lines.

Authors:  Anna Woloszynska-Read; Smitha R James; Chajoun Song; Boquan Jin; Kunle Odunsi; Adam R Karpf
Journal:  Cancer Immun       Date:  2010-07-23

6.  Methylation of sodium iodide symporter promoter correlated with aggressiveness and metastasis in papillary thyroid carcinoma: a meta-analysis.

Authors:  Jun-Yu Zhao; Huan-Jun Wang; Hai-Peng Wang; Jin-Ming Yao; Xiao-Yun Wu; Hong-Xia Shang; Rui Zhang; Huan-Gao Zhu; Jian-Jun Dong; Lin Liao
Journal:  Int J Clin Exp Med       Date:  2015-07-15

7.  Onco-exaptation of an endogenous retroviral LTR drives IRF5 expression in Hodgkin lymphoma.

Authors:  A Babaian; M T Romanish; L Gagnier; L Y Kuo; M M Karimi; C Steidl; D L Mager
Journal:  Oncogene       Date:  2015-08-17       Impact factor: 9.867

8.  Epigenetic regulation of the X-chromosomal macrosatellite repeat encoding for the cancer/testis gene CT47.

Authors:  Judit Balog; Dan Miller; Elena Sanchez-Curtailles; Jose Carbo-Marques; Gregory Block; Marco Potman; Peter de Knijff; Richard J L F Lemmers; Stephen J Tapscott; Silvère M van der Maarel
Journal:  Eur J Hum Genet       Date:  2011-08-03       Impact factor: 4.246

Review 9.  Specific changes in the expression of imprinted genes in prostate cancer--implications for cancer progression and epigenetic regulation.

Authors:  Teodora Ribarska; Klaus-Marius Bastian; Annemarie Koch; Wolfgang A Schulz
Journal:  Asian J Androl       Date:  2012-02-27       Impact factor: 3.285

10.  Frequent and distinct aberrations of DNA methylation patterns in fibrolamellar carcinoma of the liver.

Authors:  Wolfgang Tränkenschuh; Florian Puls; Matthias Christgen; Cord Albat; Albert Heim; Jeanette Poczkaj; Peer Fleming; Hans Kreipe; Ulrich Lehmann
Journal:  PLoS One       Date:  2010-10-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.